Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Epoetin Zeta Vgv Tender Gwq Serviceplus Ag. 2025-11-17
Ireland Dps Qualification For Endomechanic & Laparaoscopic, Surgical Theatre Instruments And Ophthalmic Implants To Include All Related Consumables 2025-11-18
Ireland Dps Qualification For Endomechaniclaparaoscopic, Surgical Theatre Instruments And Ophthalmic Implants To Include All Related Consumables 2025-11-18
Finland Acquisition Of Medical Workforce For The Satakunta Welfare Area (dps) 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Foreign Anhanezumab, Atc N02cd03 For The Time 01.07.2025 30.06.2027 2025-11-18
Germany Open House Pharmaceutical Department Denosumab, Atc M05bx04 2025-11-18
Germany Completion Not Excl. Pharmaceutical Discount Club. According To Section 130a (8) Sgb V By An Open House Model To The Active Ingredient Fusidic Acid/betamethasone (atc Code According To Who: D07cc01) 2025-11-18
Germany Open House Discount Contracts 2025-06 2025-11-18
Germany Completion Not Excl. Pharmaceutical Discount Club.according To Section 130a (8) Sgb V By An Open House Model To The Active Ingredient Fusidic Acid/betamethasone (atc Code According To Who: D07cc01) 2025-11-18
Germany Medicines With The Active Ingredient Rotigotine (atc 2025-11-18
Whats app